0Y

Perrigo Company PLCLSE Perrigo Stock Report

Last reporting period 28 Sep, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

3.62

Middle

Exchange

XLON - London Stock Exchange

0Y5E.L Stock Analysis

0Y

Uncovered

Perrigo Company PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-1/100

Low score

Market cap $B

3.62

Dividend yield

4.74 %

Shares outstanding

134.65 B

Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. The company is headquartered in Dublin, Dublin and currently employs 8,900 full-time employees. The firm's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.

View Section: Eyestock Rating